Glenmark will receive from Cassiopea, a subsidiary of Cosmo, the exclusive right to commercialize Winlevi in 15 EU countries
The first phase of the hospital with 225 beds built over 1.75 lakh square feet will be commissioned in the next 12 months
The medical center at the Buddh International Circuit will be under the care of the Indraprastha Apollo Hospital team
Lupin has been exclusively marketing these brands in the Indian market since July 2021
The companies will work with investigators to share the results with the scientific community
Research released at UN General Assembly week shows tests predicting heart disease and diabetes are among lowest cost solutions for improving Indian health
Will continue to own a 7.84 per cent stake in Glenmark Life Sciences with the stake reduction
AHH will make an investment of Rs. 600 crore in the company through a mix of primary and secondary infusion
Appointment further strengthens company’s expertise in fastest-growing therapeutic area to meet patient need
The market capitalization of the company stood at Rs. 7,000 crore +
Subscribe To Our Newsletter & Stay Updated
